AAAAAA

   
Results: 1-7 |
Results: 7
DIFFUSE LARGE-CELL LYMPHOMAS - IDENTIFICATION OF PROGNOSTIC FACTORS AND VALIDATION OF THE INTERNATIONAL NON-HODGKINS-LYMPHOMA PROGNOSTIC INDEX - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
Authors: NICOLAIDES C FOUNTZILAS G ZOUMBOS N SKARLOS D KOSMIDIS P PECTASIDES D KARABELIS A GIANNAKAKIS T SYMEONIDIS A PAPADOPOULOS A ANTONIOU F PAVLIDIS N
Citation: C. Nicolaides et al., DIFFUSE LARGE-CELL LYMPHOMAS - IDENTIFICATION OF PROGNOSTIC FACTORS AND VALIDATION OF THE INTERNATIONAL NON-HODGKINS-LYMPHOMA PROGNOSTIC INDEX - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Oncology, 55(5), 1998, pp. 405-415
CHEMOTHERAPY WITH METHOTREXATE, CARBOPLATIN, MITOXANTRONE (NOVANTRONE) AND VINCRISTINE (ONCOVIN) IN TRANSITIONAL-CELL UROTHELIAL CANCER
Authors: PECTASIDES D MYLONAKIS A ANTONIOU F KOSTOPOULOU M TRIANTAPHYLLIS D PAPADOPOULOU M VARTHALITIS J DIMITRIADIS M ATHANASSIOU A
Citation: D. Pectasides et al., CHEMOTHERAPY WITH METHOTREXATE, CARBOPLATIN, MITOXANTRONE (NOVANTRONE) AND VINCRISTINE (ONCOVIN) IN TRANSITIONAL-CELL UROTHELIAL CANCER, Oncology, 55(2), 1998, pp. 139-144
COMPARISON OF 2 DIFFERENT DOSES OF ONDANSETRON PLUS DEXAMETHASONE IN THE PROPHYLAXIS OF CISPLATIN-INDUCED EMESIS
Authors: PECTASIDES D MYLONAKIS A VARTHALITIS J KOSTOPOULOU M CONSTANTINOU A PAPAZACHARIOU K ANTONIOU F DIMITRIADIS M ATHANASSIOU A
Citation: D. Pectasides et al., COMPARISON OF 2 DIFFERENT DOSES OF ONDANSETRON PLUS DEXAMETHASONE IN THE PROPHYLAXIS OF CISPLATIN-INDUCED EMESIS, Oncology, 54(1), 1997, pp. 1-6
A STUDY OF THE EFFECTS OF EXTRACORPOREAL-CIRCULATION ON THE IMMUNOLOGICAL SYSTEM OF HUMANS
Authors: SIMINELAKIS S BOSSINAKOU I ANTONIOU F PALLANZA Z TOLIOS J VASILOGIANNAKOPOULOU D KASAPLI M PARIGORI P CHLAPOUTAKIS E
Citation: S. Siminelakis et al., A STUDY OF THE EFFECTS OF EXTRACORPOREAL-CIRCULATION ON THE IMMUNOLOGICAL SYSTEM OF HUMANS, Journal of cardiothoracic and vascular anesthesia, 10(7), 1996, pp. 893-898
CLINICAL-VALUE OF CA-15-3, MUCIN-LIKE CARCINOMA-ASSOCIATED ANTIGEN, TUMOR POLYPEPTIDE ANTIGEN, AND CARCINOEMBRYONIC ANTIGEN IN MONITORING EARLY BREAST-CANCER PATIENTS
Authors: PECTASIDES D PAVLIDIS N GOGOU L ANTONIOU F NICOLAIDES C TSIKALAKIS D FOUNTZILAS G
Citation: D. Pectasides et al., CLINICAL-VALUE OF CA-15-3, MUCIN-LIKE CARCINOMA-ASSOCIATED ANTIGEN, TUMOR POLYPEPTIDE ANTIGEN, AND CARCINOEMBRYONIC ANTIGEN IN MONITORING EARLY BREAST-CANCER PATIENTS, American journal of clinical oncology, 19(5), 1996, pp. 459-464
TPA, TATI, CEA, AFP, BETA-HCG, PSA, SCC, AND CA-19-9 FOR MONITORING TRANSITIONAL-CELL CARCINOMA OF THE BLADDER
Authors: PECTASIDES D BAFALOUCOS D ANTONIOU F GOGOU L ECONOMIDES N VARTHALITIS J DIMITRIADES M KOSMIDIS P ATHANASSIOU A
Citation: D. Pectasides et al., TPA, TATI, CEA, AFP, BETA-HCG, PSA, SCC, AND CA-19-9 FOR MONITORING TRANSITIONAL-CELL CARCINOMA OF THE BLADDER, American journal of clinical oncology, 19(3), 1996, pp. 271-277
TREATING UROTHELIAL TRANSITIONAL-CELL CANCER (TCC) WITH METHOTREXATE (M), CARBOPLATIN (C), NOVANTRONE (N) AND VINCRISTINE (O)
Authors: ATHANASSIOU AE PECTASIDIS D ANTONIOU F VARTHALITIS I TSINTAVIS A LYCOURINAS M DIMITRIADIS M
Citation: Ae. Athanassiou et al., TREATING UROTHELIAL TRANSITIONAL-CELL CANCER (TCC) WITH METHOTREXATE (M), CARBOPLATIN (C), NOVANTRONE (N) AND VINCRISTINE (O), European journal of cancer, 31A, 1995, pp. 1156-1156
Risultati: 1-7 |